{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:35:23Z","timestamp":1792550123581,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2020YFH0114"],"award-info":[{"award-number":["2020YFH0114"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bj.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T04:16:21Z","timestamp":1657944981000},"page":"100548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Fibroblast growth factor 21 and bone homeostasis"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-4291","authenticated-orcid":false,"given":"Yan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.bj.2022.07.002_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.625287","article-title":"Skeletal muscle and bone - emerging targets of fibroblast growth factor-21","volume":"12","author":"Sun","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.bj.2022.07.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118804","article-title":"Role of the fibroblast growth factor 19 in the skeletal system","volume":"265","author":"Chen","year":"2021","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jocd.2018.08.005","article-title":"Fibroblast growth factor 21 is associated with bone mineral density, but not with bone turnover markers and fractures in Chinese postmenopausal women","volume":"22","author":"Hu","year":"2019","journal-title":"J Clin Densitom"},{"issue":"11","key":"10.1016\/j.bj.2022.07.002_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bj.2022.07.002_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellsig.2017.08.009","article-title":"Integrated stress response stimulates FGF21 expression: systemic enhancer of longevity","volume":"40","author":"Salminen","year":"2017","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.bj.2022.07.002_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","article-title":"Adipokines in health and disease","volume":"36","author":"Fasshauer","year":"2015","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/bcp.12676","article-title":"Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study","volume":"80","author":"Dong","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","article-title":"FGF21 regulates sweet and alcohol preference","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib11","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/ijerph17061938","article-title":"Lower serum fibroblast growth factor 21 levels are associated with normal lumbar spine bone mineral density in hemodialysis patients","volume":"17","author":"Wu","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1113\/EP088351","article-title":"Age-related bone loss is associated with FGF21 but not IGFBP1 in healthy adults","volume":"105","author":"Lee","year":"2020","journal-title":"Exp Physiol"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","article-title":"The Klotho proteins in health and disease","volume":"15","author":"Kuro","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib14","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/cbdd.13588","article-title":"The role of the fibroblast growth factor family in bone-related diseases","volume":"94","author":"Wang","year":"2019","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib15","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1210\/clinem\/dgab624","article-title":"LLF580, an FGF21 analog, reduces triglycerides and hepatic fat in obese adults with modest hypertriglyceridemia","volume":"107","author":"Rader","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.bj.2022.07.002_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-021-04157-x","article-title":"Fibroblast growth factor 21 (FGF21) alleviates senescence, apoptosis, and extracellular matrix degradation in osteoarthritis via the SIRT1-mTOR signaling pathway","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yexcr.2017.05.006","article-title":"Fatty liver and FGF21 physiology","volume":"360","author":"Maratos-Flier","year":"2017","journal-title":"Exp Cell Res"},{"issue":"3","key":"10.1016\/j.bj.2022.07.002_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/dom.13560","article-title":"FGF21 decreases food intake and body weight in obese Gottingen minipigs","volume":"21","author":"Christoffersen","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bj.2022.07.002_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.601290","article-title":"FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases","volume":"11","author":"Tillman","year":"2020","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.bj.2022.07.002_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/genes12020307","article-title":"Epigenetic regulation of processes related to high level of fibroblast growth factor 21 in obese subjects","volume":"12","author":"Platek","year":"2021","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.bj.2022.07.002_bib22","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4093\/dmj.2014.38.4.245","article-title":"FGF21 as a stress hormone: the roles of FGF21 in stress adaptation and the treatment of metabolic diseases","volume":"38","author":"Kim","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1159\/000487568","article-title":"Liver plays a major role in FGF-21 mediated glucose homeostasis","volume":"45","author":"Liu","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib25","doi-asserted-by":"crossref","first-page":"048272","DOI":"10.1242\/dmm.048272","article-title":"An Fgfr3-activating mutation in immature murine osteoblasts affects the appendicular and craniofacial skeleton","volume":"14","author":"Biosse Duplan","year":"2021","journal-title":"Dis model mech"},{"issue":"8","key":"10.1016\/j.bj.2022.07.002_bib26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nm.4363","article-title":"Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice","volume":"23","author":"Benoit","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20188503","article-title":"A deep proteome and transcriptome abundance atlas of 29 healthy human tissues","volume":"15","author":"Wang","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"6220","key":"10.1016\/j.bj.2022.07.002_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bj.2022.07.002_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.021","article-title":"Metabolic fibroblast growth factors (FGFs): mediators of energy homeostasis","volume":"53","author":"Markan","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.bj.2022.07.002_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s42255-022-00572-2","article-title":"\u03b2-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130","volume":"4","author":"Geng","year":"2022","journal-title":"Nat metab"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molmet.2012.08.007","article-title":"The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue","volume":"2","author":"Adams","year":"2012","journal-title":"Mol Metabol"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.celrep.2016.08.086","article-title":"mTORC1 is a major regulatory node in the FGF21 signaling network in adipocytes","volume":"17","author":"Minard","year":"2016","journal-title":"Cell Rep"},{"issue":"37","key":"10.1016\/j.bj.2022.07.002_bib33","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bj.2022.07.002_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2017.11.002","article-title":"Fibroblast growth factor 21 in chronic kidney disease","volume":"489","author":"Anuwatmatee","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"8","key":"10.1016\/j.bj.2022.07.002_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tem.2019.05.007","article-title":"Going back to the biology of FGF21: new insights","volume":"30","author":"Lewis","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00109-016-1477-1","article-title":"FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process","volume":"95","author":"Salminen","year":"2017","journal-title":"J Mol Med"},{"issue":"9","key":"10.1016\/j.bj.2022.07.002_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024895","article-title":"Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40279-013-0100-7","article-title":"Bone quality: the determinants of bone strength and fragility","volume":"44","author":"Fonseca","year":"2014","journal-title":"Sports Med"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12020-017-1507-y","article-title":"Association between fibroblast growth factor 21 and bone mineral density in adults","volume":"59","author":"Hao","year":"2018","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.bj.2022.07.002_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biocel.2012.12.014","article-title":"Bone marrow mesenchymal stem cells: fat on and blast off by FGF21","volume":"45","author":"Wan","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib41","first-page":"727","article-title":"MicroRNA-100-5p inhibits osteoclastogenesis and bone resorption by regulating fibroblast growth factor 21","volume":"43","author":"Zhou","year":"2019","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00774-016-0745-z","article-title":"Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats","volume":"35","author":"Charoenphandhu","year":"2017","journal-title":"J Bone Miner Metab"},{"issue":"8","key":"10.1016\/j.bj.2022.07.002_bib43","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","article-title":"Inhibition of growth hormone signaling by the fasting-induced hormone FGF21","volume":"8","author":"Inagaki","year":"2008","journal-title":"Cell Metabol"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2015.09.010","article-title":"A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.bj.2022.07.002_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"10.1016\/j.bj.2022.07.002_bib47","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/dom.13023","article-title":"Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates","volume":"19","author":"Kim","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.bj.2022.07.002_bib48","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1210\/en.2014-1083","article-title":"FGF-21 and skeletal remodeling during and after lactation in C57BL\/6J mice","volume":"155","author":"Bornstein","year":"2014","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib49","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/jbmr.3932","article-title":"Increased expression of FGF-21 negatively affects bone homeostasis in dystrophin\/utrophin double knockout mice","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2013.02.019","article-title":"Interactions between FGF21 and BMP-2 in osteogenesis","volume":"432","author":"Ishida","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib51","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bbrc.2017.10.115","article-title":"Fibroblast growth factor 21 ameliorates vascular calcification by inhibiting osteogenic transition in vitamin D3 plus nicotine-treated rats","volume":"495","author":"Shi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib52","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2018.06.098","article-title":"BMP2\/Smad signaling pathway is involved in the inhibition function of fibroblast growth factor 21 on vascular calcification","volume":"503","author":"Liu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.bj.2022.07.002_bib53","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jbmr.2936","article-title":"FGF21 is not a major mediator for bone homeostasis or metabolic actions of PPARalpha and PPARgamma agonists","volume":"32","author":"Li","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41366-018-0080-7","article-title":"FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys","volume":"42","author":"Andersen","year":"2018","journal-title":"Int J Obes"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/ejcn.2011.212","article-title":"Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women","volume":"66","author":"Hinton","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"10.1016\/j.bj.2022.07.002_bib56","doi-asserted-by":"crossref","first-page":"e8791","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.bj.2022.07.002_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115673","article-title":"Pegbelfermin, a PEGylated FGF21 analogue, has pharmacology without bone toxicity after 1-year dosing in skeletally-mature monkeys","volume":"428","author":"Thompson","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bj.2022.07.002_bib58","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopha.2018.10.150","article-title":"Effect of FGF-21 on implant bone defects through hepatocyte growth factor (HGF)-mediated PI3K\/AKT signaling pathway","volume":"109","author":"Yang","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00223-011-9484-2","article-title":"Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study","volume":"88","author":"Pye","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00365513.2014.992942","article-title":"Fibroblast growth factor-21 concentration in serum and synovial fluid is associated with radiographic bone loss of knee osteoarthritis","volume":"75","author":"Li","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.bj.2022.07.002_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2015.04.001","article-title":"Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa","volume":"77","author":"Fazeli","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bj.2022.07.002_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.metabol.2017.03.014","article-title":"High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients","volume":"71","author":"Gallego-Escuredo","year":"2017","journal-title":"Metabolism"},{"issue":"17","key":"10.1016\/j.bj.2022.07.002_bib63","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.bj.2022.07.002_bib64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.bj.2022.07.002_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12882-021-02393-z","article-title":"Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study","volume":"22","author":"Zhu","year":"2021","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.bj.2022.07.002_bib66","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40618-020-01337-y","article-title":"Potential role of fibroblast growth factor 21 in the deterioration of bone quality in impaired glucose tolerance","volume":"44","author":"Lui","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3803\/EnM.2018.33.2.273","article-title":"Association between serum fibroblast growth factor 21 levels and bone mineral density in postmenopausal women","volume":"33","author":"Choi","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"10.1016\/j.bj.2022.07.002_bib68","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s00198-013-2464-9","article-title":"Fibroblast growth factor 21 (FGF21) and bone: is there a relationship in humans?","volume":"24","author":"Lee","year":"2013","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cen.13162","article-title":"Acute endurance exercise lowers serum fibroblast growth factor 21 levels in Japanese men","volume":"85","author":"Taniguchi","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib70","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.bj.2022.07.002_bib71","first-page":"77","article-title":"Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals","volume":"2","author":"Hanks","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib72","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1210\/en.2011-1909","article-title":"Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice","volume":"153","author":"Kubicky","year":"2012","journal-title":"Endocrinology"},{"issue":"31","key":"10.1016\/j.bj.2022.07.002_bib73","doi-asserted-by":"crossref","first-page":"26060","DOI":"10.1074\/jbc.M112.343707","article-title":"Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate","volume":"287","author":"Wu","year":"2012","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.bj.2022.07.002_bib74","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00330.2013","article-title":"Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine","volume":"306","author":"Keipert","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.bj.2022.07.002_bib75","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.28688","article-title":"The liver throws the skeleton a bone (resorption factor)","volume":"64","author":"Chung","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib76","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cmet.2016.05.014","article-title":"The somatotropic Axis in human aging: framework for the current state of knowledge and future research","volume":"23","author":"Milman","year":"2016","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.bj.2022.07.002_bib77","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417022001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417022001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:12:58Z","timestamp":1762420378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417022001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2319417022001020"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2022.07.002","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 21 and bone homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100548"}}